Navigation Links
INSYS Therapeutics, Inc. Announces Positive Phase III Efficacy Trial Results for Fentanyl Sublingual Spray
Date:3/8/2010

Dr. Richard Rauck, a principal investigator in the Phase III study observed, "The sublingual spray demonstrated very rapid, effective pain relief. Patients began to experience meaningful pain relief within five minutes. This observation was supported by the clinical research findings.  To date, no other transmucosal Fentanyl product has produced pain relief this quickly. This early finding is supported with continued pain relief at all subsequent time intervals.  An easy-to-use oral spray that can produce effective, potent and very rapid pain relief will be a tremendous advantage for our patients who experience moderate to severe cancer breakthrough pain."

Michael Babich, President and COO of INSYS, adds, "We are delighted to announce today's results as it validates our thesis that a delivery system that can be administered in seconds will be a benefit to patients suffering from this indication.  More importantly, the results seen at five minutes will benefit patients and doctors who may struggle to find a product that can work quickly as breakthrough pain's onset is quite rapid.  In addition, many patients may not be able to take other currently available drugs due to difficulty in swallowing, nausea or other gastrointestinal problems.  Our device and array of strengths (100 to 1600 mcg) will allow patients to be treated at their appropriate titrated level.  Finally, we were excited to see that 97% of the patients randomized to the double blind period completed the study, while 92% rolled over to the safety portion."


'/>"/>
SOURCE INSYS Therapeutics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Clinsys(R) TPS Teams Provide Comprehensive Clinical Development Plans
2. Cell Therapeutics, Inc. (CTI) Launches Phase III Study for Pixantrone in Relapsed Indolent Non-Hodgkins Lymphoma (NHL)
3. Cell Therapeutics, Inc. (CTI) Sponsors Panel Discussion on Women and Lung Cancer on Capitol Hill
4. Cell Therapeutics, Inc. (CTI) Supports Panel Discussion on Women and Lung Cancer on Capitol Hill
5. Velcura Therapeutics, Inc. Reports Positive Pre-IND Meeting With FDA and Plans Early Clinical Trials for New Drug to Treat Multiple Myeloma Bone Disease
6. NIST Awards $2 Million to Velcura Therapeutics, Inc. for Innovative Technology R&D - Dual-Action Therapies for Bone Disease
7. Ocera Therapeutics, Inc. Completes Enrollment in FHAST1, a Pivotal Phase 3 Clinical Trial in Fistulizing Crohns Disease
8. William R. Ringo Joins Hyperion Therapeutics, Inc. Board of Directors as Chairman
9. Cell Therapeutics, Inc. (CTI) Submits European Marketing Authorization Application for XYOTAX(TM)
10. Dynamis Therapeutics, Inc. Discovers RAGE Inhibitor
11. Cell Therapeutics, Inc. (CTI) Announces Enrollment Complete in Phase III EXTEND (PIX301) Clinical Trial of Pixantrone in Patients With Second or Greater Relapse of Diffuse Large B Cell NHL
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/26/2015)... Feb. 26, 2015 Legislation passed today by ... provision to help prevent inappropriate prescriptions in Medicare Part ... the Integrity of Medicare Act (PIMA) of 2014 , ... Kevin Brady (R-TX) and Ranking Member Jim McDermott ... abuse epidemic and implement the right policies, said the ...
(Date:2/26/2015)... February 26, 2015 LifeScienceIndustryResearch.com ... First -In- Class Innovations and Cost Optimization Plays ... Cap Pharmaceutical Companies research report to the pharmaceuticals ... to this Global Pharma US & EU Outlook ... measurements, divestment of non-core assets result in healthy ...
(Date:2/26/2015)...  BD Life Sciences, a segment of BD ... ), a leading global medical technology company, and ... high-resolution biology, today announced that they will be ... cell isolation and single-cell gene expression analysis. ... FACS™ single-cell sorting instrumentation and software with Cellular ...
Breaking Medicine Technology:PCMA Statement on the 'Protecting the Integrity of Medicare Act' 2Global Pharma U.S. and EU Outlook 2015 Market Research Report 2Global Pharma U.S. and EU Outlook 2015 Market Research Report 3Global Pharma U.S. and EU Outlook 2015 Market Research Report 4BD and Cellular Research Announce Co-marketing Efforts for Single-Cell Sequencing 2BD and Cellular Research Announce Co-marketing Efforts for Single-Cell Sequencing 3
... SAN FRANCISCO, June 6 OxyBand Technologies Inc., ... the company,s bio-medical,technology development and expand the company,s ... for,health, cosmetic and consumer care. The company,s inaugural ... the FDA for medical and over the,counter marketing. ...
... Data Indicate Overall and Disease-Free Survival -, ... adjuvant trial in,high-risk melanoma patients demonstrated that a ... and/or overall,survival. These findings, which indicate Leukine,s potential ... annual meeting of the American Society,of Clinical Oncology ...
Cached Medicine Technology:OxyBand Technologies, Inc. Hires a Leader in Medical Technology as Chief Technology Officer 2Study Supports Possible Use of Leukine(R) as a Potential Adjuvant Therapy for High-Risk Melanoma Patients 2Study Supports Possible Use of Leukine(R) as a Potential Adjuvant Therapy for High-Risk Melanoma Patients 3Study Supports Possible Use of Leukine(R) as a Potential Adjuvant Therapy for High-Risk Melanoma Patients 4Study Supports Possible Use of Leukine(R) as a Potential Adjuvant Therapy for High-Risk Melanoma Patients 5
(Date:2/27/2015)... MA (PRWEB) February 27, 2015 ... mobility management services, and one of the ... announced support for Bell Mobility within their CLEAN ... of services. Wireless Analytics’ newly developed Bell ... reporting for the Canadian wireless carrier’s business customers. ...
(Date:2/27/2015)... 2015 A new study published in ... men who cycle on a regular basis and prostate cancer. ... suggests that the more hours per week a man spends ... leading to an increased importance on prostate cancer screening methods. ... look more closely at patents’ risk factors for developing prostate ...
(Date:2/27/2015)... (PRWEB) February 27, 2015 ... “cutters”, are often misunderstood, misdiagnosed and therefore ... to healthy lives. Jacksonville-based addiction treatment ... of its highly acclaimed Lakeview Professional Lecture ... interested in understanding this complicated condition. ...
(Date:2/27/2015)... On March 2-4, the Mesothelioma ... Cancer Institute (NCI) will co-host the annual International ... of Health (NIH), in Bethesda, Maryland. The event ... medical professionals and scientists who specialize in mesothelioma, ... public, including patients, their families, and caregivers. , ...
(Date:2/27/2015)... Altec Products, Inc., announced today that ... as their doc-link for Dynamics Partner of the Year. ... solutions for their customers in all different industries with ... and BPW have worked side-by-side to successfully help clients ... , “We are so impressed by the success that ...
Breaking Medicine News(10 mins):Health News:Bell Mobility Gains Traction With Enterprises; Is Added to Wireless Analytics’ CLEAN Platform™ 2Health News:Bell Mobility Gains Traction With Enterprises; Is Added to Wireless Analytics’ CLEAN Platform™ 3Health News:Study Finds That Cycling Increases Risk For Prostate Cancer 2Health News:Study Finds That Cycling Increases Risk For Prostate Cancer 3Health News:Lakeview Health to Host Important Workshop Tackling the Rising Issue of ‘Cutters’ on March 27 2Health News:Conference on Mesothelioma Co-Hosted with National Cancer Institute 2Health News:Conference on Mesothelioma Co-Hosted with National Cancer Institute 3Health News:Altec Announces 2014 doc-link for Dynamics Partner of the Year Award Recipient 2Health News:Altec Announces 2014 doc-link for Dynamics Partner of the Year Award Recipient 3
... ATS 2008, TORONTOXScientists believe they may have identified a ... risk of allergy and asthma in childhood. They will ... International Conference in Toronto on Tuesday, May 20., Several ... without allergy at the time of birth. For example, ...
... 21 The Quantum Group,Inc. (Amex: QGP, QGP.WSA, QGP.WSB) ... successfully completed a corporate expansion plan. The Company,increased its ... facility size from 6,600 sq. ft. to 10,600 sq. ... to a larger facility in Doral (west,Miami), Florida., ...
... 21 Crdentia Corp. (OTC Bulletin,Board: CRDT), a leading ... ended March 31, 2008., Revenue in the quarter ... revenue of $9,806,540 and an increase of 31% over ... profit improved to,$2,310,854 in the first quarter of 2008, ...
... ACM today announced a new strategic,alignment that ... next generation technology and services to the two ... commercial plans and,payers, and federal and state governments., ... has been,named EVP/General Manager for Government, and will ...
... sleep apnea (OSA) in very young children may cause ... older children and adults with the condition, according to ... the American Thoracic Societys 2008 International Conference in Toronto ... year of life, said Aviv Goldbart, M.D., the pediatric ...
... that patients with chronic obstructive pulmonary disease (COPD) who ... visits from exacerbations or complications benefit from simple low-intensity ... for COPD was previously shown to reduce hospitalizations for ... a more limited intervention model is effective, said Kathryn ...
Cached Medicine News:Health News:Possible biological explanation for C-Section-linked allergies and asthma found 2Health News:The Quantum Group Completes Corporate Expansion Plan; Employee and Corporate Office Growth Leads the Way for Enhanced Innovation and Growth Through 2009 2Health News:The Quantum Group Completes Corporate Expansion Plan; Employee and Corporate Office Growth Leads the Way for Enhanced Innovation and Growth Through 2009 3Health News:Crdentia Announces 2008 First Quarter Results 2Health News:Crdentia Announces 2008 First Quarter Results 3Health News:Crdentia Announces 2008 First Quarter Results 4Health News:Crdentia Announces 2008 First Quarter Results 5Health News:Crdentia Announces 2008 First Quarter Results 6Health News:Crdentia Announces 2008 First Quarter Results 7Health News:ACM Taps Two Senior Leaders to Head Up New Strategic Initiatives 2Health News:Low-intensity case management cuts COPD-related hospital visits in half 2
... are designed with the clinician in mind. ... be removed to simplify cleaning - no ... unique snap-on mechanism eliminates screws that can ... interchangeable with other green coded fiber optic ...
Rigid plastic. Single use. Non-Sterile. The disposable laryngoscope blade that fits on a standard handle. Made of extremely rigid plastic. Bright white light out-performs metal blades. Single patient...
Rigid plastic. Single use. Non-Sterile. The disposable laryngoscope blade that fits on a standard handle. Made of extremely rigid plastic. Bright white light out-performs metal blades. Single patient...
... a unique fiberoptic laryngoscope blade that can ... sometimes needed during difficult intubations. The articulating ... blade to be raised by squeezing a ... operation produces a more complete exposure of ...
Medicine Products: